| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alex's Lemonade
|
Burki, Talha
|
|
2011
|
12 |
4 |
p. 331-
1 p.
|
artikel
|
| 2 |
Anti-angiogenic therapies in metastatic breast cancer—an unfulfilled dream
|
Buzdar, Aman U
|
|
2011
|
12 |
4 |
p. 316-318
3 p.
|
artikel
|
| 3 |
2011 ASCO Genitourinary Cancers Symposium
|
Brierley, Rob
|
|
2011
|
12 |
4 |
p. 330-
1 p.
|
artikel
|
| 4 |
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
|
Paranjape, Trupti
|
|
2011
|
12 |
4 |
p. 377-386
10 p.
|
artikel
|
| 5 |
Carcinogenicity of chemicals in industrial and consumer products, food contaminants and flavourings, and water chlorination byproducts
|
Grosse, Yann
|
|
2011
|
12 |
4 |
p. 328-329
2 p.
|
artikel
|
| 6 |
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|
van Hooft, Jeanin E
|
|
2011
|
12 |
4 |
p. 344-352
9 p.
|
artikel
|
| 7 |
Genetics of lung-cancer susceptibility
|
Brennan, Paul
|
|
2011
|
12 |
4 |
p. 399-408
10 p.
|
artikel
|
| 8 |
KRAS 3′-UTR variants and stratification of breast-cancer risk
|
Kumar, Madhu S
|
|
2011
|
12 |
4 |
p. 318-319
2 p.
|
artikel
|
| 9 |
MicroRNA therapeutics in preclinical cancer models
|
Kim, Minlee
|
|
2011
|
12 |
4 |
p. 319-321
3 p.
|
artikel
|
| 10 |
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study
|
Martin, Miguel
|
|
2011
|
12 |
4 |
p. 369-376
8 p.
|
artikel
|
| 11 |
New combinations for mantle cell lymphoma: concerted action needed
|
Hess, Georg
|
|
2011
|
12 |
4 |
p. 315-316
2 p.
|
artikel
|
| 12 |
NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia
|
Miller, Whitney
|
|
2011
|
12 |
4 |
p. 326-327
2 p.
|
artikel
|
| 13 |
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
|
Anderson, Benjamin O
|
|
2011
|
12 |
4 |
p. 387-398
12 p.
|
artikel
|
| 14 |
Principles for the best multidisciplinary meetings
|
Mazzaferro, Vincenzo
|
|
2011
|
12 |
4 |
p. 323-325
3 p.
|
artikel
|
| 15 |
Principles of clinical cancer genetics
|
Speicher, Michael
|
|
2011
|
12 |
4 |
p. 332-
1 p.
|
artikel
|
| 16 |
Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
|
de Gonzalez, Amy Berrington
|
|
2011
|
12 |
4 |
p. 353-360
8 p.
|
artikel
|
| 17 |
Shortages of cancer drugs in the USA
|
The Lancet Oncology,
|
|
2011
|
12 |
4 |
p. 313-
1 p.
|
artikel
|
| 18 |
Stenting for acute malignant colonic obstruction: a bridge to nowhere?
|
Song, Louis M Wong Kee
|
|
2011
|
12 |
4 |
p. 314-315
2 p.
|
artikel
|
| 19 |
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
|
Ansell, Stephen M
|
|
2011
|
12 |
4 |
p. 361-368
8 p.
|
artikel
|
| 20 |
The emperor of all maladies
|
Pai, Sanjay A
|
|
2011
|
12 |
4 |
p. 332-
1 p.
|
artikel
|
| 21 |
Value-based insurance design in oncology
|
de Souza, Jonas A
|
|
2011
|
12 |
4 |
p. 321-323
3 p.
|
artikel
|
| 22 |
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
|
Machiels, Jean-Pascal
|
|
2011
|
12 |
4 |
p. 333-343
11 p.
|
artikel
|
Tijdschrift beschrijving